久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA Approves Lampit for Chagas Disease in Pediatric Patients americanpharmaceuticalreview
    August 25, 2020
    The U.S. Food and Drug Administration (FDA) approved Lampit (nifurtimox) for the treatment of Chagas disease (American Trypanosomiasis), caused by Trypanosoma cruzi, in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg).
  • US FDA approves Lampit for the treatment of Chagas disease in children pharmaceutical-business-review
    August 12, 2020
    Bayer announced that the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease ...
PharmaSources Customer Service